NEWS » - What is the pathophysiology of gastri

Gastric Cancer Drug Development Shifting from Small Molecules to Monoclonal Antibodies Health Articles | May 2 Cheap Todd Davis Jersey , 2016

While 99% of currently marketed gastric cancer drugs are small molecules, this dominance could give way to more innovative treatments in future, as the pipeline consists of 29% monoclonal antibodies (mAbs) says new research “Gastric Cancer - Early Stage Pipeline Innovation Shows Shift towards Targeted mAbs”



Worldwide: Our Business partners GBI Research’s new report “Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift towards Targeted mAbs” analysis of the gastric cancer treatment pipeline, stratified by stage of development Cheap Domata Peko Jersey , molecule type and molecular target. It includes information on the current clinical and commercial landscape, and the composition of the gastric cancer therapeutics market in terms of dominant molecule types and targets, as well as highlighting current unmet needs.




While 99% of currently marketed gastric cancer drugs are small molecules, this dominance could give way to more innovative treatments in future Cheap Ronald Leary Jersey , as the pipeline consists of 29% monoclonal antibodies (mAbs), according to business intelligence provider GBI Research.

The company’s latest report* states that there are currently 241 products in the gastric cancer pipeline, a number of which have different mechanisms of action and targets to the dominant marketed therapies.


Download Sample:


Firas Nour, Associate Analyst for GBI Research Cheap Colby Wadman Jersey , says that while y is seeking novel approaches to treating gastric cancer.


- Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been further reviewed in greater detail.


- Identify commercial opportunities in the gastric cancer deals landscape by analyzing trends in licensing and co-development deals and producing a list of gastric cancer therapies that are not yet involved in deals Cheap Adam Gotsis Jersey , and may be potential investment ric Cancer Drug Development Shifting from Small Molecules to Monoclonal Antibodies


聽


Scope:

- What is the pathophysiology of gastric cancer?


- How is gastric cancer diagnosed?